相关实验视频
Updated: Sep 8, 2025

04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
444
基于AMPA受体分布的双相情绪障碍和主要抑郁症之间的区别
Sakiko Tsugawa1,2, Yuichi Kimura3, Junichi Chikazoe4
1Department of Physiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Frontiers in neural circuits
|August 20, 2025
概括
准确诊断双相情感障碍 (BD) 和主要抑郁障碍 (MDD) 是一个挑战. 新的研究表明,使用PET扫描测量α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid受体 (AMPAR) 密度可以帮助区分BD和MDD患者.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 医疗成像医学成像
背景情况:
- 准确诊断双相情感障碍 (BD) 和主要抑郁障碍 (MDD) 是临床上重要的,但具有挑战性.
- 对α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid受体 (AMPARs) 的失调与精神疾病有关.
- 使用像[11C]K-2这样的标记物进行正子发射断层扫描 (PET) 成像提供了一种可视化AMPAR分布的方法.
研究的目的:
- 开发和验证一个机器学习模型,使用AMPAR密度来区分BD和MDD.
- 评估[11C]K-2 PET成像在抑郁发作期间区分BD和MDD的诊断效用.
主要方法:
- 用[11C]K-2和结构性MRI进行PET扫描,对16名BD和27名MDD患有抑郁症的患者进行了扫描.
- 使用PET图像的标准化吸收值比率 (SUVR) 来量化AMPAR密度.
- 一个部分最小平方模型与离开-一对-排除交叉验证被用来预测诊断.
主要成果:
- 在BD和MDD患者之间,在叶,小脑和背侧前额叶皮层中发现了AMPAR密度的显著差异.
- 机器学习模型的曲线下面积 (AUC) 为0.80,灵敏度为75.0%,特异性为77.8%.
- 这些结果表明BD和MDD之间存在明显的突触表型.
结论:
- 通过[11C]K-2 PET成像测量AMPAR密度可以有效地区分BD和MDD.
- 这种基于成像的方法可以作为一个有价值的诊断生物标志物,特别是在模两可的情况下.
- 进一步的研究可以完善这种方法,以改善情绪障碍的临床诊断.
相关概念视频
Bipolar Disorder
142
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
142
Long-term Depression
31.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.4K
Depressive Disorders: MDD and Dysthymia
207
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
207
Mania and Antimanic Drugs: Overview
318
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
318
Antidepressant Drugs: MAOIs and Other Agents
337
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
337
Depression: Overview
331
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
331

